PP405 shows promise for hairgrowth but may need continuous use like Minoxidil. Current treatments include Minoxidil, finasteride, and dutasteride, with skepticism about a true cure due to financial interests.
Breezula's phase 3 results are expected soon, but its release is likely delayed until 2027 or 2028. The discussion highlights the need for more hairgrowth stimulants like AMP-303 and PP-405, as current treatments like Dutasteride effectively stop hair loss but don't regrow hair.
Hair loss treatments like Breezula and PP405 are delayed, with approvals taking years, while existing treatments like minoxidil and finasteride remain popular. New treatments like Clascoterone and Veradermics are in trials, but high costs and lengthy approval processes slow their release.
Minoxidil can help with hairgrowth but not prevent hair loss, while finasteride is recommended to stop hair loss. Combining both treatments is suggested for better results, but side effects should be monitored.
A user with stage 3 baldness is seeking advice on microneedling for hairgrowth, including pre and post-care, washing routines, and the use of hairgrowth serums or oils. They also inquire about the effectiveness and safety of microneedling pens.